Sage Capital Advisors,Llc Pfizer Inc Transaction History

Sage Capital Advisors,Llc

$374 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $1.69 Million - $2.17 Million	-43,027 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $146,584 - $166,055	4,082 Added 10.48%	43,027 $1.77 Million
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $10,549 - $11,897	315 Added 0.82%	38,945 $1.41 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $8,200 - $10,427	245 Added 0.64%	38,630 $1.35 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $7,143 - $8,381	225 Added 0.59%	38,385 $1.41 Million
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $4,005 - $4,859	-133 Reduced 0.35%	38,160 $1.25 Million
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $83,955 - $119,953	3,106 Added 8.83%	38,293 $1.25 Million
Q4 2019 Jan 16, 2020	BUY	$32.92 - $37.36 $28,113 - $31,905	854 Added 2.49%	35,187 $1.38 Million
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $6,562 - $8,510	202 Added 0.59%	34,333 $1.23 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $14,459 - $16,234	-391 Reduced 1.13%	34,131 $1.47 Million
Q1 2019 Jul 31, 2019	SELL	$37.5 - $41.2 $791,812 - $869,938	-21,115 Reduced 37.95%	34,522 $1.47 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $96,937 - $106,502	-2,585 Reduced 4.44%	55,637 $2.36 Million
Q4 2018 Jul 31, 2019	SELL	$38.47 - $43.86 $812,332 - $926,147	-21,116 Reduced 26.62%	58,222 $2.54 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $219,202 - $249,914	5,698 Added 7.74%	79,338 $3.46 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $17,131 - $20,779	497 Added 0.68%	73,640 $3.25 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $10,157 - $10,829	308 Added 0.42%	73,143 $2.65 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $24,953 - $28,949	782 Added 1.09%	72,835 $2.59 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $13,669 - $14,504	411 Added 0.57%	72,053 $2.61 Million
Q3 2017 Jul 31, 2019	SELL	$31.0 - $34.15 $14,725 - $16,221	-475 Reduced 0.66%	71,642 $2.56 Million
Q3 2017 Nov 30, 2017	BUY	$31.0 - $34.15 $88,567 - $97,566	2,857 Added 4.13%	72,117 $2.58 Million
Q2 2017 Jul 31, 2019	SELL	N/A	-475 Reduced 0.68%	69,260 $2.33 Million
Q2 2017 Aug 08, 2017	BUY	N/A	69,735	69,735 $2.34 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.67 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.33 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.44 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Account